CN102264672A - 使用转移氢化制备旋光化合物的方法 - Google Patents

使用转移氢化制备旋光化合物的方法 Download PDF

Info

Publication number
CN102264672A
CN102264672A CN2009801523437A CN200980152343A CN102264672A CN 102264672 A CN102264672 A CN 102264672A CN 2009801523437 A CN2009801523437 A CN 2009801523437A CN 200980152343 A CN200980152343 A CN 200980152343A CN 102264672 A CN102264672 A CN 102264672A
Authority
CN
China
Prior art keywords
compound
phenol
dimethylaminoethyl
preparing compound
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801523437A
Other languages
English (en)
Chinese (zh)
Inventor
C·马特斯
M·福克斯
M·凯塞尔格鲁伯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40344210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102264672(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN102264672A publication Critical patent/CN102264672A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/002—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN2009801523437A 2008-12-24 2009-12-23 使用转移氢化制备旋光化合物的方法 Pending CN102264672A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0823554.1A GB0823554D0 (en) 2008-12-24 2008-12-24 Process for the preparation of optically active compounds using transfer hydrogenation
GB0823554.1 2008-12-24
PCT/EP2009/067821 WO2010072798A1 (en) 2008-12-24 2009-12-23 Process for the preparation of optically active compounds using transfer hydrogenation

Publications (1)

Publication Number Publication Date
CN102264672A true CN102264672A (zh) 2011-11-30

Family

ID=40344210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801523437A Pending CN102264672A (zh) 2008-12-24 2009-12-23 使用转移氢化制备旋光化合物的方法

Country Status (22)

Country Link
US (2) US8415508B2 (enExample)
EP (1) EP2382172A1 (enExample)
JP (1) JP2012513966A (enExample)
KR (1) KR20110098964A (enExample)
CN (1) CN102264672A (enExample)
AR (1) AR075496A1 (enExample)
AU (1) AU2009331493B2 (enExample)
BR (1) BRPI0923394A2 (enExample)
CA (1) CA2748349A1 (enExample)
CL (1) CL2011001563A1 (enExample)
CO (1) CO6382153A2 (enExample)
EC (1) ECSP11011221A (enExample)
GB (1) GB0823554D0 (enExample)
IL (1) IL213520A0 (enExample)
MA (1) MA32983B1 (enExample)
MX (1) MX2011006918A (enExample)
MY (1) MY151103A (enExample)
NZ (1) NZ593493A (enExample)
SG (1) SG172052A1 (enExample)
TN (1) TN2011000290A1 (enExample)
TW (1) TW201035028A (enExample)
WO (1) WO2010072798A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193600A (zh) * 2012-01-07 2013-07-10 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法
CN105246873A (zh) * 2013-06-14 2016-01-13 日产化学工业株式会社 光学活性醇化合物的制造方法
CN109608442A (zh) * 2018-09-12 2019-04-12 广州新民培林医药科技有限公司 一种嘧啶衍生物和制备方法及其应用
CN109809967A (zh) * 2019-03-04 2019-05-28 陕西师范大学 一种合成手性醇的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
US4996235A (en) * 1987-11-25 1991-02-26 Eli Lilly And Company 3,4-diphenylbutanamines
JPH0899940A (ja) * 1994-09-30 1996-04-16 Kanegafuchi Chem Ind Co Ltd 光学活性な１−（３，４−ジメトキシフェニル）−２−アミノプロパンの製造法
GB9706321D0 (en) 1997-03-26 1997-05-14 Zeneca Ltd Catalytic hydrogenation
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−３、５−（トリフルオロメチル）ベンジルアミンの製造方法
KR20030062447A (ko) 2000-12-25 2003-07-25 아지노모토 가부시키가이샤 광학 활성 할로하이드린 화합물의 제조방법
DE602004017747D1 (de) * 2003-07-08 2008-12-24 Unilever Nv Verfahren zur herstellung einer kosmetisch aktiven verbindung
GB0329284D0 (en) 2003-12-18 2004-01-21 Avecia Ltd Process
US20070225528A1 (en) 2004-03-29 2007-09-27 Nagoya Industrial Science Research Center Process for Producing Optically Active Alcohol
US6939981B1 (en) * 2004-06-25 2005-09-06 Eastman Chemical Company Ruthenium complexes of phosphine-aminophosphine ligands
WO2006048720A1 (en) * 2004-11-08 2006-05-11 Emcure Pharmaceuticals Limited An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2006137167A1 (ja) * 2005-06-20 2006-12-28 Kanto Kagaku Kabushiki Kaisha スルホナート触媒及びそれを利用したアルコール化合物の製法
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007147897A1 (de) 2006-06-23 2007-12-27 Basf Se Verfahren zur herstellung von optisch aktiven 2-halogen-1-phenylethanol-derivaten und folgeprodukten davon
WO2009132443A1 (en) 2008-05-01 2009-11-05 Kanata Chemical Technologies Inc. Cationic transition-metal arene catalysts

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193600A (zh) * 2012-01-07 2013-07-10 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
CN103193600B (zh) * 2012-01-07 2016-04-06 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
CN105246873A (zh) * 2013-06-14 2016-01-13 日产化学工业株式会社 光学活性醇化合物的制造方法
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法
CN109608442A (zh) * 2018-09-12 2019-04-12 广州新民培林医药科技有限公司 一种嘧啶衍生物和制备方法及其应用
CN109608442B (zh) * 2018-09-12 2020-08-21 广东莱恩医药研究院有限公司 一种嘧啶衍生物和制备方法及其应用
CN109809967A (zh) * 2019-03-04 2019-05-28 陕西师范大学 一种合成手性醇的方法
CN109809967B (zh) * 2019-03-04 2022-03-18 陕西师范大学 一种合成手性醇的方法

Also Published As

Publication number Publication date
CO6382153A2 (es) 2012-02-15
SG172052A1 (en) 2011-07-28
CL2011001563A1 (es) 2012-01-13
US8415508B2 (en) 2013-04-09
ECSP11011221A (es) 2011-08-31
WO2010072798A1 (en) 2010-07-01
NZ593493A (en) 2013-03-28
JP2012513966A (ja) 2012-06-21
MY151103A (en) 2014-04-15
US8637713B2 (en) 2014-01-28
EP2382172A1 (en) 2011-11-02
US20100168229A1 (en) 2010-07-01
TN2011000290A1 (en) 2012-12-17
MA32983B1 (fr) 2012-01-02
AU2009331493B2 (en) 2013-03-07
KR20110098964A (ko) 2011-09-02
BRPI0923394A2 (pt) 2016-01-12
AU2009331493A1 (en) 2011-07-07
MX2011006918A (es) 2011-07-29
US20130096337A1 (en) 2013-04-18
IL213520A0 (en) 2011-07-31
GB0823554D0 (en) 2009-01-28
CA2748349A1 (en) 2010-07-01
AR075496A1 (es) 2011-04-06
TW201035028A (en) 2010-10-01

Similar Documents

Publication Publication Date Title
CN101622225B (zh) 炔丙基氨基茚分离方法
JP2020529414A (ja) ピロリジン化合物を調製するためのプロセス
WO2020052545A1 (zh) 布瓦西坦的制备方法及其中间体
US8637713B2 (en) Process for preparation of optically active compounds using transfer hydrogenation
JP2012519677A (ja) シナカルセト及びその塩の製造方法、並びに該方法に使用する中間体
AU2011222644A1 (en) Improved resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol
EP3199516B1 (en) Process for the preparation of metaraminol
TW200831478A (en) Chromane derivatives, synthesis thereof, and intermediates thereto
KR20070057703A (ko) 거울상 이성체적으로 순수한 아토목세틴 및 토목세틴만델레이트
CN116836069B (zh) 一种盐酸左沙丁胺醇的制备方法
WO2011131027A1 (zh) .l-苯福林盐酸盐的制备方法
CN101228109A (zh) 立体异构n，n-二烷基氨基-2-烷基-3-苯基烷烃的拆分
US20100063160A1 (en) Polymorphs of o-desmethyl venlafaxine succinate
CN115991655A (zh) 一种重酒石酸间羟胺及其关键中间体对映异构体的合成方法和产品
CN111377850B (zh) 一种手性n-取代-3,3-二氟-4-羟基哌啶衍生物及其制备方法
EP3068746B1 (en) Process for the preparation of enantiomerically pure 1-aminoindan
WO2011050499A1 (zh) 盐酸西那卡塞的合成方法
WO2011073362A1 (en) Process for the preparation of optically active compounds using pressure hydrogenation
HK40064096A (en) A preparation method of l-salbutamol hydrochloride
CN100473640C (zh) 一种光学纯反式2，3－二胺－1，2，3，4－四氢化萘的制备方法
KR100351623B1 (ko) 수용성 키랄 보조제로서의(5ｒ,5'ｒ)-5,5'-비스(옥사졸리딘-2-온) 및 이의 제조방법
HUE029760T2 (en) A method for preparing ivabradine and synthesizing a process for the preparation of its intermediate product
EP2476665A1 (en) Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
JP2005126380A (ja) 光学活性な１，２−ビス（３，５−ジメチルフェニル）−１，２−エタンジアミンの製造方法
SK15972002A3 (sk) Spôsob prípravy a čistenia tramadolu a tramadol hydrogénchloridu

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111130